Datavault AI Licenses Smart Contracts IP to Wellgistics Health for PharmacyChain Integration

Datavault AI Inc. (NASDAQ: DVLT) has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) for integration into the PharmacyChain and EinsteinRx platforms. This strategic partnership enables Web 3.0 smart contract functions across a network of more than 6,500 pharmacies and supports Wellgistics' comprehensive plan to modernize U.S. pharmaceutical distribution through advanced data automation and AI integration.

The licensing agreement represents a significant advancement in pharmaceutical supply chain management, allowing for streamlined prescription tracking and substantial reduction in PBM-driven costs. By implementing Datavault AI's smart contracts technology, Wellgistics aims to enhance transparency for payers while creating more efficient operational workflows throughout the pharmaceutical distribution ecosystem. The integration of Web 3.0 capabilities into established pharmacy platforms marks a transformative step toward digitizing traditional pharmaceutical processes.

Datavault AI's technology portfolio includes the Information Data Exchange (IDE) platform, which enables Digital Twins and facilitates the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects. This approach fosters responsible AI implementation with integrity while providing comprehensive solutions across multiple industries. The company's cloud-based platform offers AI and Machine Learning automation, third-party integration capabilities, detailed analytics, and marketing automation features that can be customized to meet specific industry requirements.

The partnership leverages Datavault AI's expertise in high-performance computing and Web 3.0 technologies to address longstanding challenges in pharmaceutical distribution. By implementing smart contracts across Wellgistics' extensive pharmacy network, the companies aim to create a more transparent, efficient, and cost-effective system for prescription management and distribution. This collaboration represents the convergence of advanced AI technologies with practical healthcare applications, potentially setting new standards for pharmaceutical supply chain management in the United States.

Additional information about Datavault AI's developments and corporate updates can be found through the company's newsroom at https://ibn.fm/DVLT. The full details of the licensing agreement and strategic partnership are available in the official press release accessible at https://ibn.fm/MLaEZ. This partnership between two NASDAQ-listed companies demonstrates the growing importance of AI and blockchain technologies in transforming traditional healthcare and pharmaceutical operations through innovative digital solutions.